Compare HUT & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HUT | TNDM |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 1.5B |
| IPO Year | N/A | 2013 |
| Metric | HUT | TNDM |
|---|---|---|
| Price | $38.73 | $21.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 16 |
| Target Price | ★ $50.75 | $23.56 |
| AVG Volume (30 Days) | ★ 6.7M | 2.1M |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.89 | N/A |
| Revenue | $178,318,000.00 | ★ $1,007,001,000.00 |
| Revenue This Year | $74.79 | $8.59 |
| Revenue Next Year | $116.78 | $10.19 |
| P/E Ratio | $21.20 | ★ N/A |
| Revenue Growth | 5.60 | ★ 17.87 |
| 52 Week Low | $10.04 | $9.98 |
| 52 Week High | $57.29 | $38.28 |
| Indicator | HUT | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 46.25 | 62.69 |
| Support Level | $34.18 | $20.27 |
| Resistance Level | $47.20 | $24.50 |
| Average True Range (ATR) | 4.37 | 1.21 |
| MACD | -0.36 | -0.04 |
| Stochastic Oscillator | 35.94 | 49.65 |
Hut 8 Corp is an energy infrastructure operator and Bitcoin miner with self-mining, hosting, managed services, and traditional data center operations across North America. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.